These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10942102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
    Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F.
    Cancer Res; 1998 Jul 01; 58(13):2876-80. PubMed ID: 9661905
    [Abstract] [Full Text] [Related]

  • 5. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.
    Coradini D, Pellizzaro C, Veneroni S, Ventura L, Daidone MG.
    Br J Cancer; 2002 Nov 04; 87(10):1105-11. PubMed ID: 12402149
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY, Kim SH, Choi BB, Kim SH, Sung MS.
    World J Surg Oncol; 2015 Mar 15; 13():113. PubMed ID: 25889560
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.
    Nurismah MI, Noriah O, Suryati MY, Sharifah NA.
    Asian Pac J Cancer Prev; 2008 Mar 15; 9(4):699-702. PubMed ID: 19256762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.
    Ilic IR, Djordjevic NP, Randjelovic PJ, Stojanovic NM, Radulovic NS, Ilic RS.
    J BUON; 2016 Mar 15; 21(5):1113-1120. PubMed ID: 27837612
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS, Yang Q, Haffty BG.
    Breast J; 2009 Mar 15; 15(6):571-8. PubMed ID: 19995377
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ.
    Anticancer Res; 1999 Mar 15; 19(3A):2133-9. PubMed ID: 10470161
    [Abstract] [Full Text] [Related]

  • 14. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
    Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ.
    Am J Clin Pathol; 1996 Apr 15; 105(4):394-402. PubMed ID: 8604681
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M, Athanassiadou AM, Patsouris E, Tsipis A, Dimopoulos S, Kyriakidou V, Chelidonis G, Athanassiadou P.
    Pathol Res Pract; 2011 Jun 15; 207(6):377-82. PubMed ID: 21621926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.
    Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A.
    J Clin Pathol; 2014 Sep 15; 67(9):768-71. PubMed ID: 24996432
    [Abstract] [Full Text] [Related]

  • 20. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
    Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, Su CC, Chen DR.
    Breast; 2013 Oct 15; 22(5):968-73. PubMed ID: 23787124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.